Societe Generale’s Avanos Medical AVNS Stock Holding History

Societe Generale’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$400K	Buy	+12,309	New	+$377K	﹤0.01%	1829

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Societe Generale's AVNS Position: Q2 2016 in Review

Societe Generale opened a new position in Avanos Medical (AVNS) in Q2 2016: 12,309 shares worth $400K. The stake represents ﹤0.01% of the portfolio and ranks #1829 among its holdings.

351 funds tracked by Wall St. Rank hold AVNS as of Q2 2016.

Societe Generale held 12,309 shares of Avanos Medical worth $400K as of Q2 2016.
Avanos Medical was a new Societe Generale position in Q2 2016.
Avanos Medical made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1829 holding.
351 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.